Evidence map›Paper›PMID 23826079›Full record

ArticlePloS one2013

Regulation of Constitutive GPR3 Signaling and Surface Localization by GRK2 and β-arrestin-2 Overexpression in HEK293 Cells.

Katie M Lowther, Tracy F Uliasz, Konrad R Götz, Viacheslav O Nikolaev, Lisa M Mehlmann

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Building a resilient ovarian reserve: Early soma-oocyte interactions.Current topics in developmental biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. The development of diphenyleneiodonium analogs as GPR3 agonists.Bioorganic & medicinal chemistry letters · 2023
    Article
  7. Endocannabinoid signaling pathways: beyond CB1R and CB2R.Journal of cell communication and signaling · 2021
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Katie M LowtherDepartment of Cell Biology, University of Connecticut Health Center, Farmington, Connecticut, United States of America.
Tracy F Uliasz
Konrad R Götz
Viacheslav O Nikolaev
Lisa M Mehlmann
UConn Health · US

Funding

Signaling mechanisms that regulate meiosis in mammalian oocytesR01HD056366 · NICHD · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MEHLMANN, LISA M · 2007 to 2011
$1.3M
Cytoplasmic Maturation in Mouse OocytesR56HD056366 · NICHD · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MEHLMANN, LISA M · 2017 to 2017
$300k
NICHD NIH HHS R01 HD056366NICHD NIH HHS R56 HD056366
6 · The paper itself

Abstract

G protein-coupled receptor 3 (GPR3) is a constitutively active receptor that maintains high 3'-5'-cyclic adenosine monophosphate (cAMP) levels required for meiotic arrest in oocytes and CNS function. Ligand-activated G protein-coupled receptors (GPCRs) signal at the cell surface and are silenced by phosphorylation and β-arrestin recruitment upon endocytosis. Some GPCRs can also signal from endosomes following internalization. Little is known about the localization, signaling, and regulation of constitutively active GPCRs. We demonstrate herein that exogenously-expressed GPR3 localizes to the cell membrane and undergoes internalization in HEK293 cells. Inhibition of endocytosis increased cell surface-localized GPR3 and cAMP levels while overexpression of GPCR-Kinase 2 (GRK2) and β-arrestin-2 decreased cell surface-localized GPR3 and cAMP levels. GRK2 by itself is sufficient to decrease cAMP production but both GRK2 and β-arrestin-2 are required to decrease cell surface GPR3. GRK2 regulates GPR3 independently of its kinase activity since a kinase inactive GRK2-K220R mutant significantly decreased cAMP levels. However, GRK2-K220R and β-arrestin-2 do not diminish cell surface GPR3, suggesting that phosphorylation is required to induce GPR3 internalization. To understand which residues are targeted for desensitization, we mutated potential phosphorylation sites in the third intracellular loop and C-terminus and examined the effect on cAMP and receptor surface localization. Mutation of residues in the third intracellular loop dramatically increased cAMP levels whereas mutation of residues in the C-terminus produced cAMP levels comparable to GPR3 wild type. Interestingly, both mutations significantly reduced cell surface expression of GPR3. These results demonstrate that GPR3 signals at the plasma membrane and can be silenced by GRK2/β-arrestin overexpression. These results also strongly implicate the serine and/or threonine residues in the third intracellular loop in the regulation of GPR3 activity.

Indexed as

Animalsbeta-Arrestin 2Cell MembraneCyclic AMPDynaminsEndocytosisG-Protein-Coupled Receptor Kinase 2HEK293 CellsHumansIntracellular SpaceMiceMutationPhosphorylationProtein DomainsProtein Kinase InhibitorsReceptors, G-Protein-CoupledARRB2 protein, humanbeta-Arrestin 2Cyclic AMPDynaminsGPR3 protein, humanGPR3 protein, mouseG-Protein-Coupled Receptor Kinase 2GRK2 protein, humanProtein Kinase InhibitorsReceptors, G-Protein-Coupled

Identifiers

PMID23826079
PMCPMC3694969
OpenAlexW2093037443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.